Institutional Perspectives in Psychiatry: Addressing Challenges in Depression Treatment

Video

Subhdeep Virk, MBBS, chaired the recent State of the Science event on treatment-resistant depression.

Treatment-resistant depression was the main topic during HCPLive’s® recent State of the Science event called Institutional Perspectives in Psychiatry: Addressing Challenges in Depression Treatment.

The program was chaired by Subhdeep Virk, MBBS, of The Ohio State University.

Virk focused on newer treatment options for depression.

Joining Virk during the March 3 event were her colleagues from Ohio State—Douglas Misquitta, MD, Kevin Reeves, MD, and Nagy Youssef, MD, PhD.

Misquitta presented on the burden of treatment-resistant depression, Reeves presented on integrating patient care, and Youssef talked about current treatment interventions for treatment-resistant depression.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.